Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Chawla (Jodhpur, India), V. Sharma (Jodhpur, India), S. Jain (Jaipur, India), V. Joshi (Jaipur, India), R. Niwas (Jodhpur, India). Osteoporosis and its relation with severity of COPD and steroids use. 4301

Member's Comments

No comment yet.

Related content which might interest you: Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids Source: Annual Congress 2006 - COPD therapy Year: 2006 Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes Source: International Congress 2014 – Markers Year: 2014 Osteoporosis risk associated with chronic corticoid inhalation therapy in patients with COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Comparison of osteoporosis in male smokers with or without COPD Source: International Congress 2016 – Smoking-related diseases Year: 2016 Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study Source: Eur Respir J, 57 (2) 2000515; 10.1183/13993003.00515-2020 Year: 2021 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Prevalence of extra-pulmonary comorbidities in COPD patients and its correlation with severity of disease Source: International Congress 2014 – Latest insights in chronic care Year: 2014 Long-term inhaled corticosteroid use in COPD and the risk of fracture in men and women Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Evaluation of the relationship between COPD and osteoporosis in Japanese patients Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Assessing COPD profiles and outcomes by dyspnoea severity Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Relationship between pharmacotherapy and severity of disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 73s Year: 2007 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Physical status and dependence levels in patients with COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015